Monomeric nucleoprotein of influenza A virus

PLoS Pathog. 2013 Mar;9(3):e1003275. doi: 10.1371/journal.ppat.1003275. Epub 2013 Mar 28.

Abstract

Isolated influenza A virus nucleoprotein exists in an equilibrium between monomers and trimers. Samples containing only monomers or only trimers can be stabilized by respectively low and high salt. The trimers bind RNA with high affinity but remain trimmers, whereas the monomers polymerise onto RNA forming nucleoprotein-RNA complexes. When wild type (wt) nucleoprotein is crystallized, it forms trimers, whether one starts with monomers or trimers. We therefore crystallized the obligate monomeric R416A mutant nucleoprotein and observed how the domain exchange loop that leads over to a neighbouring protomer in the trimer structure interacts with equivalent sites on the mutant monomer surface, avoiding polymerisation. The C-terminus of the monomer is bound to the side of the RNA binding surface, lowering its positive charge. Biophysical characterization of the mutant and wild type monomeric proteins gives the same results, suggesting that the exchange domain is folded in the same way for the wild type protein. In a search for how monomeric wt nucleoprotein may be stabilized in the infected cell we determined the phosphorylation sites on nucleoprotein isolated from virus particles. We found that serine 165 was phosphorylated and conserved in all influenza A and B viruses. The S165D mutant that mimics phosphorylation is monomeric and displays a lowered affinity for RNA compared with wt monomeric NP. This suggests that phosphorylation may regulate the polymerisation state and RNA binding of nucleoprotein in the infected cell. The monomer structure could be used for finding new anti influenza drugs because compounds that stabilize the monomer may slow down viral infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Circular Dichroism
  • Crystallization
  • Influenza A virus / chemistry
  • Influenza A virus / metabolism*
  • Influenza A virus / ultrastructure
  • Mutation
  • Particle Size
  • Phosphorylation
  • Protein Multimerization
  • Protein Structure, Secondary
  • Protein Structure, Tertiary
  • RNA, Viral / chemistry
  • Ribonucleoproteins / chemistry
  • Ribonucleoproteins / metabolism*
  • Viral Proteins / chemistry
  • Viral Proteins / metabolism*

Substances

  • RNA, Viral
  • Ribonucleoproteins
  • Viral Proteins

Grants and funding

This work was funded in part by the French Agency for Research (ANR) (FLUNUCLEOVIR N° ANR 2010 Blan 1307 01), the European Commission under grant agreement no259751 (Flupharm project: New drugs targeting influenza virus polymerase, 11/2010-05/2014), a grant from the French A(H1N1) research program, coordinated by the Institut de Microbiologie et Maladies Infectieuses (INSERM, France) and by Lyon Biopôle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.